SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014052
Filing Date
2022-08-03
Accepted
2022-08-03 10:01:10
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-20220630.htm   iXBRL 10-Q 3422835
2 EX-10.1 mcrb-ex10_1.htm EX-10.1 31604
3 EX-31.1 mcrb-ex31_1.htm EX-31.1 17032
4 EX-31.2 mcrb-ex31_2.htm EX-31.2 16904
5 EX-32.1 mcrb-ex32_1.htm EX-32.1 10562
6 EX-32.2 mcrb-ex32_2.htm EX-32.2 10522
  Complete submission text file 0000950170-22-014052.txt   11050702

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20220630.xsd EX-101.SCH 66988
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20220630_lab.xml EX-101.LAB 505455
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20220630_pre.xml EX-101.PRE 375306
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mcrb-20220630_cal.xml EX-101.CAL 58583
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20220630_def.xml EX-101.DEF 199823
74 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20220630_htm.xml XML 2073172
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 221131236
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences